Gainers
- TFF Pharmaceuticals (NASDAQ:TFFP) stock moved upwards by 27.9% to $2.63 during Friday's pre-market session. The company's market cap stands at $9.1 million.
- Centene (NYSE:CNC) stock rose 12.62% to $69.4. The market value of their outstanding shares is at $36.5 billion. As per the news, the Q3 earnings report came out today.
- Nexalin Technology (NASDAQ:NXL) shares rose 9.31% to $2.35. The market value of their outstanding shares is at $24.8 million.
- Citius Oncology (NASDAQ:CTOR) shares increased by 8.76% to $1.31. The company's market cap stands at $93.4 million.
- Actinium Pharma (AMEX:ATNM) shares increased by 8.33% to $1.82. The company's market cap stands at $56.7 million.
- BioVie (NASDAQ:BIVI) shares rose 8.11% to $2.93. The market value of their outstanding shares is at $23.3 million.
Losers
- Monopar Therapeutics (NASDAQ:MNPR) stock fell 23.9% to $24.85 during Friday's pre-market session. The company's market cap stands at $87.4 million.
- Quince Therapeutics (NASDAQ:QNCX) stock declined by 15.97% to $1.0. The company's market cap stands at $43.2 million.
- Bionomics (NASDAQ:BNOX) stock declined by 14.89% to $0.31. The market value of their outstanding shares is at $4.0 million.
- Hepion Pharmaceuticals (NASDAQ:HEPA) shares decreased by 11.01% to $0.65. The company's market cap stands at $3.7 million.
- Dogwood Therapeutics (NASDAQ:DWTX) stock fell 10.11% to $4.27. The market value of their outstanding shares is at $5.6 million.
- Passage Bio (NASDAQ:PASG) shares decreased by 9.91% to $0.58. The market value of their outstanding shares is at $35.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BIVIBioVie Inc
$1.595.30%
CNCCentene Corp
$35.33-0.08%
CTORCitius Oncology Inc
$1.36-0.73%
DWTXDogwood Therapeutics Inc
$5.60-0.71%
HEPAHepion Pharmaceuticals Inc
$0.0650-79.6%
MNPRMonopar Therapeutics Inc
$81.01-2.90%
NXLNexalin Technology Inc
$1.261.60%
PASGPassage Bio Inc
$7.69-0.13%
QNCXQuince Therapeutics Inc
$1.75-2.23%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
